Cullinan Oncology Licenses U.S. Rights to the First
CAMBRIDGE, Mass., Feb. 13, 2023 (GLOBE NEWSWIRE) -- Cullinan Oncology, Inc. (Nasdaq: CGEM) and Harbour BioMed (HKEX:
Globe Newswire14-02-2023, 07:09
Vista to Highlight Continued Growth and Leadership in Asia Pacific at BAAFEx 2025 19-02-2025, 13:30